Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
AK4 Monoclonal Antibody (OTI2D1), TrueMAB™, OriGene

Mouse Monoclonal Antibody
Supplier: OriGene TA503307S


Description
AK4 Monoclonal antibody specifically detects AK4 in Canine, Human samples. It is validated for Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western BlotSpecifications
AK4 | |
Monoclonal | |
0.91 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
P27144 | |
Mouse | |
Affinity chromatography | |
RUO | |
205, 489554 | |
-20° C, Avoid Freeze/Thaw Cycles | |
IgG1 |
Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot | |
OTI2D1 | |
Unconjugated | |
AK4 | |
adenylate kinase 3 alpha-like 1; Adenylate kinase 3-like; adenylate kinase 3-like {ECO:0000255; adenylate kinase 3-like 1; adenylate kinase 3-like 2; adenylate kinase 4; adenylate kinase 4, mitochondrial; adenylate kinase 4, mitochondrial {ECO:0000255; Adenylate kinase isoenzyme 4; adenylate kinase isoenzyme 4, mitochondrial; adenylate kinase isoenzyme 4, mitochondrial; adenylate kinase 4, mitochondrial; AK 4; AK 4 {ECO:0000255; AK3; Ak-3; Ak3b; Ak3l1; AK3L2; AK4; Ak-4; ATP-AMP transphosphorylase; D4Ertd274e; GTP:AMP phosphotransferase AK4; GTP:AMP phosphotransferase AK4 {ECO:0000255; GTP:AMP phosphotransferase AK4, mitochondrial; HAMAP-Rule:MF_03170}; mitochondrial adenylate kinase-3; nucleoside-triphosphate-adenylate kinase; RP4-686B20.1 | |
Full length human recombinant protein of human AK4 produced in HEK293 cell. | |
30 μL | |
Primary | |
Canine, Human | |
Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction